Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Instruments Plc LSE:OXIG London Ordinary Share GB0006650450 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -26.00 -1.58% 1,622.00 1,622.00 1,636.00 1,666.00 1,614.00 1,656.00 5,083 12:59:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 333.6 35.5 52.4 31.0 931

Oxford Instruments Share Discussion Threads

Showing 551 to 574 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
22/1/2015
11:46
the one encouraging statement today is We expect to see the Group grow next year and beyond as we execute on our nanotechnology strategy. Of course there's still a chance this optimism will be misplaced but £4 looks as pessimistic as it can be so is probably just wishful thinking. I prefer to wait of the dust to settle and await the actual results before trying to value the stock.
alter ego
22/1/2015
11:40
What did you say your name was ?
wad collector
22/1/2015
10:51
Looking for an entry point below £4 in next 12 months. Don't think I'll be disappointed.
billy_liar
22/1/2015
10:49
Taking 2015 estimates into account it would appear that normalised eps will be back to the level in 2012. so agree with AE: view above. Realistic p/e should be lower at say 14 - 15 particularly given the level of DEBT - According to refs is was £140M in 2014 accounts [88.7%] Need however to do more research on products as to what percentage are MUST have (i.e. unique with no easily substitutable competitors] so far as customers are concerned and which are at major risk for competitive activity.
pugugly
22/1/2015
10:24
I'm in below £8.
cafe tabou
22/1/2015
09:32
what % of revenue does Russia account for ?? thanks
abcd1234
22/1/2015
09:07
Arrgh down £3. 22 January 2015 Release date: 7am 22(nd) January 2015 Oxford Instruments plc Quarter 3 Trading Update 22 January 2015 Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues a Quarter 3 Trading Update which covers the period from 1st October 2014 to date. In the third quarter organic orders and revenues were similar to the same period last year. In addition, Andor the acquisition made in the fourth quarter last year continues to perform well. Significant orders, both taken in the year and forecast to be taken in Quarter 4, are for delivery to Russia. Recent tightening in the application of trade sanctions and, in particular the cancelling of certain export licences mean we no longer expect to convert theses orders to sales. We now assume that no sales can be made to Russia for the remainder of this year and we are also assuming no sales to Russia next year. In addition, our forecast of recovery in the Japanese market has not yet occurred. The effects of Russia and Japan, combined with weaker trading in our short lead-time Industrial Analysis business means that, whilst we expect revenues for the second half to be ahead of the same period last year, we believe they will fall short of market expectations. We now anticipate adjusted profit before tax for the current year will be approximately GBP35 million. In response to these challenges we are taking action to reduce costs and improve efficiency. Subject to consultation this may result in the closure of some sites and a reduction in headcount. This project aims to produce a cost saving of GBP6 million in the next financial year. The one off, cash costs of achieving these savings are expected to be in the region of GBP5 million which will be taken as an exceptional item in the current year. Whilst it is not possible to predict when the situation in Russia will recover, order intake in Japan is improving. We expect to see the Group grow next year and beyond as we execute on our nanotechnology strategy. End A quick look looks like a classic market overreaction to me , so in cavalier fashion just added a lump at 808.
wad collector
22/1/2015
09:05
trading update worse than I expected: www.investegate.co.uk/oxford-instruments--oxig-/rns/trading-statement/201501220700208176C/ In addition, our forecast of recovery in the Japanese market has not yet occurred. The effects of Russia and Japan, combined with weaker trading in our short lead-time Industrial Analysis business means that, whilst we expect revenues for the second half to be ahead of the same period last year, we believe they will fall short of market expectations. We now anticipate adjusted profit before tax for the current year will be approximately £35 million. back of envelope calculation suggest eps will be around 47p so currently on p/e of about 17.4. Still looks overvalued in the short term IMO.
alter ego
15/1/2015
11:57
Someone's interested. Fascinating co that would make a useful target for someone such as GE?
small crow
06/1/2015
07:23
Thanks for your thoughts, Alter. Thought had a bit more in it, but hard to tell.
tratante
05/1/2015
15:48
tratante, I may not be totally objective here as I recently sold my holding believing OXIG to be overvalued. However, looking at the forecast for year end 3/15, it shows expected eps of 61.7p and at around 1200p the p/e is still 19.5 - hardly good value for a stock that is expected to show a fall in earnings this year and lacking much of a dividend yield to support the share price Given the general market it's not surprising to me that the share price is showing signs of weakness.
alter ego
05/1/2015
15:43
No, but familiar daily pattern...
small crow
05/1/2015
15:25
Anyone know any material reason why this is falling back today?
tratante
31/12/2014
10:33
Not quite!
wad collector
24/12/2014
20:15
Promising run again this week ; will it touch £13 before the year is out?
wad collector
19/12/2014
09:14
Potential for INV H&S.
bamboo2
18/12/2014
16:02
Agree ; hate watching paper gains drift away untapped..
wad collector
18/12/2014
15:03
wad collector - also tempted but succumbed. Will aim to buy again if/when share price drifts down as it appears inclined to do. Not my normal style but short term outlook isn't exciting and a profit is a profit.
alter ego
18/12/2014
14:52
Up 5% today on no visible OXIG-specific news , tempted to take a 2 month 33% profit .The narrow spread is appealing to the trader in me , but I am going to sit on hands for now ; this is a quality company in a good niche. The yield is low but well covered.
wad collector
17/11/2014
15:48
Strange patterns of trades in this stock. Anyone know what might be happening?
small crow
17/11/2014
13:50
A flurry of broker adjustments , FWIW. Liberum , Beayfort and Berenberg still say Buy but reduced targets to 1200 and 1360. JPM overweight but target down to 1360 . Numis say add to 1350 , Singer Hold to 1350 Investec are thinking about it . I don't why I am posting this really , they would appear to be guessing...
wad collector
21/10/2014
08:16
The quick 10% has come , but I think I will go for the slow 50% instead...
wad collector
10/10/2014
09:07
Well , 940 was too much for me to resist . Have patiently watched these since I sold a couple of years ago. More speculative than most of my holdings but a good chance of a quick 10% I suspect...or a slow 50% .
wad collector
03/10/2014
08:34
I am looking to buy OXIG once it successfully holds above £10.50p I asked the kind gent that is dasv on the SHA thread to have look at their underlying metrics for me and this is what he found. It is NOT pretty! Followed by my reply. ----------------------- dasv 3 Oct'14 - 07:36 - 34568 of 34580 c2i: OXIG ROCE too low for me: 6.8% (I like 12%+) Free cash flow and operating cash flow lower than EPS. Big difference between reported and normalised EPS - what's that about? 32m cash but 124m debt of all of a sudden? Debt is forecast to increase into 2016 Altman z1-score is 2.33 - Caution EPS growth forecast -6.76% forecast. 2016E forecast +14.3% with a PEG of 0.85 so a turnaround by then? Pays a divi - can it continue to do so with this cash/debt situation? Brokers habe been lowering forecasts consistently over the last 12 months but retain a "buy" rating. --- I haven't looked at the story on OXIG for a while. I'd be interested to hear what are your thoughts on why it's a long from here? ---------------------- contrarian2investor 3 Oct'14 - 09:25 - 34579 of 34581 0 0 edit Good morning dasv, Thank you for taking the time to find those metrics for OXIG, very much appreciated. Here are some of my reasons for looking at OXIG: The area of nanotechnology (and graphene) could be growth drivers and OXIG could eventually be one of those winners. The integration of ANDOR (with its high performance optical cameras and software which are used in both the physical and bio sciences) at some point could be significant drivers for growth. Currency headwinds are now working in their favour. Order book appears robust Their new X-MET8000 handheld (X-ray fluorescence) XRF analyser should fly off the shelves. A potential turnaround candidate, with the outlier being that it becomes a bolt-on target for a larger peer. Henderson Global Investors increased its stake in OXIG to 5.45% on 26th September
contrarian2investor
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
Your Recent History
LSE
OXIG
Oxford Ins..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200220 13:25:53